DAB2 and hepatocellular carcinoma: Additionally, SCFAs have been implicated in upregulating tumor suppressors such as Disabled homolog 2 (DAB2), inhibiting Ras signaling, and blocking the progression from chronic viral liver disease to HCC (McBrearty et al., 2021).